Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 20 | 16,000 | 0 |
| Gross Profit | N/A | N/A | 20 | 16,000 | N/A |
| Operating Expenses | 2,565 | 3,602 | 2,565 | 2,778 | 2,119 |
| Operating Income | -2,565 | -3,602 | -2,545 | 13,222 | -2,119 |
| Other Income | 406 | 189 | 323 | 231 | -60 |
| Pre-tax Income | -2,159 | -3,413 | -2,222 | 13,453 | -2,178 |
| Net Income Continuous | -4,224 | -3,413 | -2,222 | 13,453 | -2,269 |
| Net Income | $-4,224 | $-3,413 | $-2,222 | $13,453 | $-2,269 |
| EPS Basic Total Ops | -2.40 | -0.81 | -0.53 | 4.67 | -0.80 |
| EPS Basic Continuous Ops | -2.40 | -0.81 | -0.53 | 4.67 | 0.20 |
| EPS Diluted Total Ops | -1.25 | -0.81 | -0.53 | 3.46 | -0.80 |
| EPS Diluted Continuous Ops | -1.24 | -0.81 | -0.53 | 3.46 | 0.20 |
| EPS Diluted Before Non-Recurring Items | -1.04 | -0.81 | -0.53 | N/A | N/A |
| EBITDA(a) | $-2,559 | $-3,496 | $-2,539 | $13,227 | $-2,111 |